Quartz·2 min read·medium
Eli Lilly is allowing more patients early access to its experimental weight loss drug
✦AI Summary
Eli Lilly is expanding early access to its experimental weight loss medication for patients who do not qualify for clinical trials. The company will now review individual requests submitted by doctors.
The drugmaker said it will review requests from doctors for patients who cannot enroll in a clinical trial
businesshealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in